Intensive lifestyle intervention may increase the risk for cardiovascular disease for type 2 diabetes patients with overweight or obesity and poor glucose control.
Patients with type 1 and type 2 diabetes have a high risk of cardiovascular disease (CVD), but now, a new study shows that type 1 diabetes patients are more susceptible to both cardiovascular and renal disease.
Type 2 diabetes mellitus (T2DM) is associated with an increased risk for Parkinson disease (PD), as well as more rapid PD progression.
The researchers’ aim was to quantify shoulder disorders using physical exam and ultrasound imaging in patients with both type 2 diabetes and shoulder pain.
Vitamin D supplementation is associated with a 13% decrease in progression to diabetes in patients with prediabetes.
The USPSTF recommends screening for prediabetes and type 2 diabetes in overweight or obese adults aged 35 to 70 years.
Certain hemoglobin variants and conditions have been shown to affect red blood cell lifespan and hence may lead to false HbA1c results.
Overweight or obese men frequently have low serum testosterone concentrations, which is associated with increased risk of type 2 diabetes.
Although different insulin analogs, pumps, and sensors have been proven to work, studies have shown that few children and adolescents achieve recommended HbA1c targets.
Certain risk factors were consistent predictors of DFU hospitalization regardless of FDS phase, making a case for a temporal shift of inpatient care strategies over those decades.
Physicians and parents have ranked important features of conducting type 1 diabetes screening tests, which is crucial due to the increasing prevalence of type 1 diabetes in children.
Study authors assessed registry data to evaluate the risk of developing childhood chronic inflammatory diseases dependent on disease status of the parents.
Breast cancer risk in women with type 2 diabetes may be influenced by long-term metformin use, according to recent study results.
Concomitant treatment of common comorbidities of HS, including anxiety and depression, metabolic syndrome, and smoking, may improve treatment outcomes.
The researchers assessed the rate of diabetic retinopathy progression in pregnant women with type 1 diabetes and its predictors.
Researchers assessed the association between inflammatory disease activity and incident diabetes mellitus in patients with rheumatoid arthritis.
A new study confirms that the timing of meals affects cardiometabolic risk factors and the ability to lose weight.
The effects of combined verinurad and febuxostat treatment were independent of blood pressure.
Study findings suggest NSAIDs may be a risk factor for acute kidney injury and hyperkalemia in patients with diabetes.
Duration-dependent beneficial effects of metformin, sulfonylurea, and thiazolidinedione use on COPD exacerbation have been observed in patients with COPD and diabetes.